Common Variable Immunodeficiency (CVID), APDS / PASLI

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Common Variable Immunodeficiency (CVID), APDS / PASLI trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2/3

NCT02435173

Study of Efficacy of CDZ173 in Patients With APDS/PASLI

This study was designed to explore CDZ173, a selective PI3Kδ inhibitor, in patients with genetically activated PI3Kδ, i.e., patients with Activated phosphoinosi…

United States, Belarus +3 more37 participantsStarted 2015-08-24

Treatment: CDZ173, Placebo